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Myeloid cell leukemia-1 (MCL-1L) is a pro-survival member of the BCL-2 family that promotes cell
survival. In this study, we identify a new splicing variant of human MCL-1 that encodes MCL-1ES
(extra short). Sequence analysis indicates that this variant results from splicing within the ﬁrst cod-
ing exon of MCL-1 at a non-canonical GC–AG donor–acceptor pair. The deduced sequence of MCL-1ES
encodes a protein of 197 amino acids, and the PEST (proline, glutamic acid, serine, and threonine)
motifs present in MCL-1L are absent. MCL-1ES interacts with MCL-1L and induces mitochondrial cell
death, suggesting that alternative splicing of MCL-1 may control the fate of cells.
Structured summary:
MINT-7255705, MINT-7255718, MINT-7255731, MINT-7255743: MCL1-ES (uniprotkb:Q07820-2) physi-
cally interacts (MI:0914) with MCL1-1L (uniprotkb:Q07820-1) by anti tag coimmunoprecipitation
(MI:0007)
MINT-7255771: MCL1-ES (uniprotkb:Q07820-2) physically interacts (MI:0914) with Beta actin
(uniprotkb:P60709) by anti tag coimmunoprecipitation (MI:0007)
MINT-7255781: MCL1-ES (uniprotkb:Q07820-2) physically interacts (MI:0914) with GAPDH
(uniprotkb:P04406) by anti tag coimmunoprecipitation (MI:0007)
MINT-7255756: MCL1-ES (uniprotkb:Q07820-2) physically interacts (MI:0914) with COX IV
(uniprotkb:P13073) by anti tag coimmunoprecipitation (MI:0007)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Apoptosis, a genetically conserved programmed cell death, is
essential for maintaining normal cellular homeostasis, and its
aberrant regulation leads to a variety of disorders. BCL-2 family
proteins are central regulators of apoptosis and consist of both
anti-apoptotic and pro-apoptotic members based on their
structure and function. MCL-1 (Myeloid cell leukemia-1) is a
non-redundant anti-apoptotic member of the BCL-2 family that is
critical for the survival of various cell types [1,2].
The bcl-2-related genes undergo alternative splicing to yield dif-
ferent isoforms that often vary in their subcellular localization,
function, and levels of expression [3]. Previously, two alternative
splicing variants of the human MCL-1 gene, MCL-1L and MCL-1S,
were identiﬁed [4–6]. Exons I–III of MCL-1 encode the pro-survival
MCL-1L protein, but splicing out exon II produces the cell death-
inducing protein MCL-1S [5]. MCL-1L is the major transcript foundchemical Societies. Published by E
ee), +82 31 725 8350 (J. Bae).
yeon@cha.ac.kr (J. Bae).in cells over MCL-1S but altered rheostat has been reported in pre-
eclampsic placenta [7].
In this study, we present a new variant of human MCL-1 encod-
ing MCL-1ES (MCL-1 extra short; GenBank accession # FJ917536)
that functions in the regulation of cell death and survival.
2. Materials and methods
2.1. RNA extraction
Total RNA was extracted from various human cell lines with In-
tron Total RNA Extraction Kits (Intron, Seungnam, Korea). The con-
centration and quality of RNA were determined with an ND-1000
spectrophotometer (NanoDrop, Waltham, MA, USA).
2.2. Reverse transcription (RT)-polymerase chain reaction (PCR)
analysis
Full-length cDNA was synthesized using the SuperScriptITM or
the Thermo SuperScriptITM First-strand Synthesis System (Invitro-
gen, Carlsbad, CA, USA) and standard PCR was performed.lsevier B.V. All rights reserved.
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Primers of sequence 50-AGTGGATCCATGTTTGGCCTCAAAA-
GAAAC-30 and 50-CTAGAATTCTTACAGTAAGGCTATCTT-30 were
used for RT-PCR to amplify the transcript variant. The product
was gel extracted, digested with BamHI and XhoI (Roche, Pleasan-
ton, CA, USA), and subsequently ligated to pcDNA3 (Invitrogen).
Cloning of MCL-1L into pcDNA3 MCL-1L has been reported previ-
ously [5].
2.4. Cell culture and transfection
Meg-01 cells were cultured in RPMI 1640medium (Gibco, Carls-
bad, CA, USA) while 293T and HeLa cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) (Gibco). Transfection
of cells was performed as described previously [8].
2.5. Immunoﬂuorescence analysis
Twenty-four hours after transfection, 293T cells were ﬁxed
with 4% paraformaldehyde, permeabilized with 0.2% Triton-X-
100, and incubated with blocking buffer (PBS containing 2% FBS
and 0.01% NaN3). The cells were then incubated with antibodiesFig. 1. Identiﬁcation and sequence analysis of MCL-1ES, a novel transcript variant of MC
and detected by gel electrophoresis (upper panel). Lanes 1–9 represent cell lines (KM121
used to produce cDNAs. RT-PCR performed using MCL-1ES-speciﬁc primers produced a D
was ampliﬁed as a template control (lower panel). (B) The nucleotide and inferred aminin PBS containing 0.1% Tween 20. For localization of mitochondria,
cells were incubated with MitoTracker (Invitrogen) for 15 min be-
fore ﬁxation. For detection of Flag-MCL-1ES, cells were incubated
with anti-Flag polyclonal antibodies (Sigma) and Alexa Fluor 488
goat anti-rabbit IgG (Invitrogen). Fluorescence was detected using
a Zeiss LSM 510 META confocal microscope (Carl Zeiss, Gottingen,
Germany).
2.6. Immunoprecipitation and Western blot analysis
Immunoprecipitation and Western blot analysis were con-
ducted according to a previous report [8]. For the detection of
MCL-1L and MCL-1ES proteins, anti-MCL-1L (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) or anti-Flag polyclonal antibodies
(Sigma, St. Louis, MO, USA) were used, respectively.
2.7. XTT assay
XTT assays were conducted using the WelCountTM Kit (Wel-
gene, Seoul, Korea) 24 h post transfection. The spectrophotometric
absorbance of each sample was measured using a multiplate read-
er (PerkinElmer, Waltham, MA, USA) at a wavelength of 450 nm,
while reference absorbance was detected at 690 nm.L-1. (A) MCL-1L, -S, and -ES were ampliﬁed by RT-PCR using MCL-1 speciﬁc primers
4, DU-145, NCL-H596, AGS, A172, SVG-P-12, WI-26, WI-38 and CHA3, respectively)
NA fragment that migrated at the predicted size of 509 bp (middle panel). GAPDH
o acid sequences of MCL-1ES are compared with those of MCL-1L.
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(MMP)
Mitochondrial integrity was determined by assaying the loss of
mitochondrial membrane potential (Dwm) uisng the MitoProbe JC-
1 (5,50,6,60-tetrachloro-1,10,3,30-tetraethylbenzimidazolcarbocya-
nine iodide) Assay Kit for ﬂow cytometry (Invitrogen), following
the instructions of the manufacturer. Brieﬂy, 293T cells
(1.0  106) were plated on 60 mm dishes and transfected with a to-
tal of 3 lg of the respective plasmid DNA. Cells were harvested
with trypsin-EDTA (Welgene) after 24 h of incubation, and the
samples were then incubated with 2 lM of JC-1 for 15 min at
37 C with 5% CO2. After washing the cells with PBS, ﬂow cytomet-
ric analyses via FACS Caliber (BD Biosciences, Franklin Lakes, NJ,
USA) were performed.
2.9. Cytochrome c release
Using a subcellular fractionation method [9] involving digitonin
(Sigma), the cytosolic and heavy membrane fractions were sepa-
rated and analyzed by Western blotting with antibodies speciﬁc
for Flag-tag, MCL-1, cytochrome c (Santa Cruz Biotechnology),
b-actin (Santa Cruz Biotechnology), and COX IV (Invitrogen).
2.10. Statistical analysis
Signiﬁcance values of results compared to the controls were
determined by the Student’s t-test.Fig. 2. Veriﬁcation of the MCL-1ES transcript. (A) The predicted scheme of MCL-1ES der
numbers of corresponding nucleotides are shown. Substituted nucleotides (A242G, T5
designed primer to conﬁrm the presence of mutated nucleotides. (B) Experimental strate
efﬁciency by Taq DNA polymerase. (C) RT-PCR analyses were performed using speciﬁc pri
residues (701A, 960T, and 1046T) in MCL-1L from HeLa cDNA prepared by thermostable R
A. These speciﬁc PCR primers for MCL-1ES or -L produced single, visible DNA products at
and 6). Primers used for each lane are: lane 1 (rs), 2 (rt), 3 (ru), 4 (rv), 5 (rw3. Results
3.1. Cloning of MCL-1ES from human cells
During a course of experiments attempting to identify MCL-1
variants in human cells, we detected a minor RT-PCR product using
cDNA synthesized with an MCL-1 speciﬁc primer (Fig. 1A: upper
panel). The size of the product did not correspond to MCL-1L or
its known splicing variant MCL-1S [5]. The 594-bp RT-PCR product
was also detected in various human cancer and immortalized cell
lines, along with two other RT-PCR products synthesized from
MCL-1L and MCL-1S transcripts (Fig. 1A: upper panel). This novel,
and extra-short, transcript was present in human tissues (Supple-
mentary Fig. 1S) and cells that had been exposed to different apop-
totic stimuli (Supplementary Fig. 2S). Intramolecular template-
switching (TS) during RT can produce a shorter transcript as an
artifact of RT; this can be avoided through the use of thermostable
reverse transcriptase [10]. Thus, to exclude the possibility that the
shorter transcript of MCL-1 was a false alternative transcript, we
performed RT reactions with thermostable reverse transcriptase
at 55 C rather than 42 C and analyzed the PCR products. The
shortest transcript of MCL-1 was still detectable (Supplementary
Fig. 3S), indicating the existence of a previously unknown tran-
script variant of MCL-1.
After cloning and sequencing the product, it was revealed that it
is a shorter variant of MCL-1L, which we named MCL-1ES. The
transcript of MCL-1ES encodes a 197-amino acid protein
(Fig. 1B). Compared to the longest MCL-1L splice variant (compris-ivation. The PEST, BH1-3, and transmembrane (TM) domains are depicted. Residue
01A, and T587A) are indicated with asterisks. Arrows indicate the region of each
gy using 30 matched or mismatched primers that would allow differential extension
mers (Table 1) for 242G, 501A, and 587A nucleotides in MCL-1ES and corresponding
T. The positions of complementary sequences in each primer are shown by arrows in
the expected sizes (MCL-1ES-speciﬁc: lanes 1, 3, and 5; MCL-1L-speciﬁc: lanes 2, 4,
), and 6 (rx).
Table 1
Sequences of primer pairs for RT-PCR analysis.
Primer # Primer sequencesa (50 ? 30) Expected sizeb (bp)
r ATGTTTGGCCTCAAAAGAAAC
s CTTCGTTTTTGATGTCCAGTT 721
t CTTCGTTTTTGATGTCCAGTC 262
u CCACCTTCTAGGTCCTCTACA 980
v CCACCTTCTAGGTCCTCTACT 521
w ACTTACAGTAAGGCTATCTTA 1066
x ACTTACAGTAAGGCTATCTTT 603
y GAGGGCGACTTTTGGCC 509
a Bolded nucleotides are speciﬁc for either MCL-ES or MCL-1L.
b Estimated size of PCR products by using the forward primerr, except fory is
indicated.
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1 resulting in loss of the PEST motifs but retention of the BH1 to 3
and transmembrane domains (Fig. 2A). Interestingly, MCL-1ES con-
tains three mutations at 242G, 501A, and 587A, encoding amino
acids 81R, 167Q, and 196K, respectively (Figs. 1B and 2A). Their
corresponding residues in MCL-1L are 701A (234K), 960T (320H),
and 1046T (349I).
3.2. Validating the MCL-1ES transcript
To further verify the existence of the MCL-1ES transcript in the
cell, we designed a MCL-1ES-speciﬁc PCR primer (Table 1), the se-
quence of which was complementary to the joining region of the
truncated exon 1. This sense primer (y) could not effectively bind
cDNA that had been synthesized from MCL-1L or MCL-1S tran-
scripts (Fig. 2A). RT-PCR using the MCL-1ES-speciﬁc PCR primerFig. 3. Intracellular localization of MCL-1ES protein. 293T cells were transfected with 60
anti-Flag antibody and MitoTracker. Flag-MCL-1ES protein was visualized using Alexa Flu
or Flag-MCL-1ES. Lysates were prepared 24 h after transfection, separated into heavy memunambiguously detected MCL-1ES transcript in various cell lines
(Fig. 1A, middle panel) indicating the existence of MCL-1ES tran-
script in these cells.
To further corroborate the existence of MCL-1ES transcript in
the cell, we designed separate sets of RT primers that could be pref-
erentially extended from each of the three mutated residues (242G,
501A or 587A) present in the MCL-1ES transcript (Table 1). These
primers contain 3 0 -terminal bases that can base-pair with either
wild-type (primers s, u, and w) or mutated (primers t, v, and
x) sequences at the mutated positions (Fig. 2B). It has been shown
that the extension efﬁciency of reverse transcriptase for mis-
matched base pairs at template-primer 30-termini is approximately
102  104 times lower than that for matched base pairs [11]. Fur-
thermore, the extension efﬁciency of Taq DNA polymerase for mis-
matched base pairs at template-primer 30-termini is much lower
than that of reverse transcriptase [11,12]. Applying these princi-
ples, we performed RT-PCR with primers speciﬁc for MCL-1ES or
MCL-1L transcripts. The resulting PCR products were the expected
sizes for the coding region of MCL-1ES (lane #: 2, 4, and 6) and
MCL-1L (lane #: 1, 3, and 5) when using MCL-1ES-speciﬁc primers
(t, v, and x) or MCL-1L-speciﬁc primers (s, u, and w), respec-
tively (Fig. 2C).
To further rule out any possibility of substitutions resulting
from RT-PCR error, four independent clones were obtained from
each cDNA prepared from CHA3, 293T, and HeLa cells. Sequence
analysis of 12 clones revealed the same three nucleotide substitu-
tions in all clones (data not shown). We also sequenced genomic
DNA fragments encompassing the regions of varied nucleotides
to discriminate single nucleotide polymorphisms (SNP) from the
mutated sequences of MCL-1ES. We found no allele having such
mutations among the genomes of CHA3, 293T, and HeLa cells (datang (A) or 200 ng (B) of plasmid encoding Flag-MCL-1ES. The cells were stained with
or 488 goat anti-rabbit IgG. (C) 293T cells were transfected with 3 lg empty pcDNA3
brane and cytosolic fractions, and immunoblotted with their respective antibodies.
Fig. 4. In vivo interaction of MCL-1ES with MCL-1L and MCL-1ES-induced mitochondrial cell death. (A) 293T cells were transfected with empty pcDNA3, Myc-MCL-1ES, or
Flag-MCL-1L. Lysates were immunoprecipitated with anti-Myc or anti-MCL-1 antibodies and immunoblotted with anti-MCL-1 or anti-Myc, respectively. (B) 293T cells were
transfected with empty pcDNA3 (), Myc-MCL-1L, Flag-MCL-1L, MCL-1ES, or Myc-MCL-1ES. Lysates were immunoprecipitated with either anti-Myc or anti-Flag antibodies
and immunoblotted using anti-Flag or anti-Myc antibodies, respectively. (C) XTT assays were performed in 293T, HeLa, and Meg-01 cells after transfection of MCL-1ES, MCL-
1L, or both plasmids. An equal amount of plasmid DNA was used. Two independent experiments were performed in triplicate. Data are presented as the percentage
(mean ± S.D.) absorbance (A450  A690) relative to the control. (D) Changes in MMP were measured by FACS analysis after incubation of the cells with JC-1. 293T cells were
transfected with 1.5 lg of plasmid encoding MCL-1L and BAK. For MCL-1ES expressing cells, either 1.5 or 3 lg of plasmid was used. Data are from three independent
experiments (means ± S.D.) and presented as the percentage of MMP relative to the empty vector control. (E) Representative FACS scatter plots of (D) are shown. The
increasing population of cells with decreased ratio of JC-1 in the red/green ﬂuorescence intensity is shown in the lower right quadrant, and the percentage of cells over the
total population is also indicated. (F) The release of cytochrome c was assessed from 293T cells transfected with the same amount of the respective plasmids. The cytosolic
and the heavy membrane fractions were separated and analyzed by Western blotting with respective antibodies. Statistically signiﬁcant values relative to the control are
marked with asterisks (P < 0.05).
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Fig. 4 (continued)
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Taken together, these results strongly indicate that the MCL-1ES
transcript is a unique splice variant that can be found endoge-
nously within the cell.3.3. Intracellular localization of MCL-1ES
To determine the intracellular localization of MCL-1ES protein,
ﬂuorescence confocal microscopic analyses were conducted.
Over-expressed MCL-1ES in 293T cells was largely cytoplasmic
with a punctate pattern, while a signiﬁcant portion of the MCL-
1ES protein was localized to mitochondria as determined by the
mitochondrion-selective probe MitoTracker (Fig. 3A and B). The
presence of MCL-1ES in both cytosolic and heavy membrane frac-
tions was also conﬁrmed by Western blot (Fig. 3C).3.4. Association of MCL-1ES with MCL-1L
The ectopically expressed Myc-tagged MCL-1ES migrates
around 25 kDa in SDS–PAGE (Fig. 4A). The over-expressed MCL-
1ES efﬁciently immunoprecipitates with both endogeneous and
ectopically expressed MCL-1L (Fig. 4A). Changes in expression of
endogenous MCL-1ES protein could not be determined due to lack
of a functional antibody, even with over-expressed MCL-1ES. No
commercially available anti-MCL-1 antibodies could detect MCL-
1ES (sc-56151, sc-958, and sc-819 from Santa Cruz; data not
shown), suggesting that the conformation of MCL-1ES lacking the
PEST motifs is considerably different from MCL-1L. We also foundthat MCL-1L does not homodimerize and co-expression of MCL-
1ES did not cause any change (Fig. 4B).
3.5. Induction of apoptosis by MCL-1ES
To investigate the function of MCL-1ES, we conducted cellular
viability assays. Transfection of a plasmid encoding MCL-1ES mod-
erately decreased viabilities of 293T, HeLa, and Meg-01 cells
(Fig. 4C). Interestingly, cell survival was greatly decreased when
cells over-expressed MCL-1L, a survival-promoting isoform, along
with MCL-1ES (Fig. 4C). In order to elucidate the mechanism by
which MCL-1ES induces cell death, changes in MMP were assessed
using the metachromatic ﬂuorochrome JC-1 (5,50,6,60-tetrachloro-
1,10,3,30-tetraethylbenzinidazolcarbocyanine iodide). While the
survival molecule MCL-1L decreased MMP, MCL-1ES enhanced
MMP signiﬁcantly (Fig. 4D and E). Co-expression of MCL-1ES with
MCL-1L further antagonized mitochondrial integrity to a compara-
ble extent elicited by BAK overexpression (Fig. 4D and E). Further-
more, MCL-1ES enhanced release of mitochondrial cytochrome c,
and co-expression with MCL-1L exacerbated the effect, comparable
to cytochrome c release induced by BAX or BAK (Fig. 4F). However,
the MCL-1ES protein did not associate with either BAX or BAK in
293T cells (Supplementary Fig. 4S).4. Discussion
We have identiﬁed MCL-1ES as a novel variant of MCL-1 that
interacts with MCL-1L and induces mitochondrial cell death.
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MCL-1L not only failed to promote the survival of cells but also in-
creased the potency of MCL-1ES to induce apoptosis.
Previous studies predicted the presence of three exons in MCL-
1 based on canonical GT–AG donor–acceptor genomic sequences
[5,6]. Comparative sequence analysis of MCL-1L and MCL-1ES re-
vealed a non-canonical donor–acceptor pair (GC–AG) at the junc-
tion of the deleted region (Fig. 1B). According to the Information
for Coordinates of Exons (ICE) database, which contains more than
91 000 known donor–acceptor splice sites from human genes, the
GC–AG pair is the second most common splice site [13]. There-
fore, the region absent in MCL-1ES possibly represents a previ-
ously unidentiﬁed intron of MCL-1. Similarly, splicing of another
BCL-2 family gene, BCL-x, within the ﬁrst coding exon results in
BCL-xS, which lacks 63 amino acids; this variant binds to anti-
apoptotic the BCL-xL protein and inhibits its cell survival activity
[14].
When direct repeats are present in regions immediately up- and
downstream of potential splice sites, truncated messages can ap-
pear in cDNA synthesis reactions (caused by intramolecular TS dur-
ing RT) and be misinterpreted as splicing variants; this RT artifact
can be avoided through the use of thermostable reverse transcrip-
tase [10]. To exclude this possibility, we analyzed MCL-1 sequences
and found that MCL-1 does not possess direct repeats of six to
twelve nucleotides at the boundary of the potential splice site. In
addition, the MCL-1ES transcript was still detectable by PCR from
cDNA synthesized using thermostable reverse transcriptase
(Supplementary Fig. 1S). These results indicate that the novel
MCL-1ES transcript present here is a genuine splice variant. Indeed,
sequence alignment of multiple Mcl-1 from various species re-
vealed that Porcine Mcl-1 (NP_999526) and chicken Mcl-1
(XP_001233735) lack the sequences absent in MCL-1ES (data not
shown). Since the function of these Mcl-1 proteins has yet to be
determined, future comparative analysis with MCL-1ES could be
beneﬁcial for understanding its role in the cell.
MCL-1ES possesses three varied nucleotides at A242G, T501A,
and T587A compared to MCL-1L, each encoding a substituted ami-
no acid (Fig. 2A). Sequence-speciﬁc RT-PCR, which utilizes the inef-
ﬁcient extension of base mismatches by reverse transcriptase and
Taq DNA polymerase at template-primer 30-termini (Fig. 2B), con-
ﬁrmed the existence of the mutated nucleotides in the MCL-1ES
transcript (Fig. 2C). While we conﬁrmed the existence of the nucle-
otide substitutions in the MCL-1ES transcript, we were not able to
identify their origin. It is possible that they arose frommechanisms
at the posttranscriptional level such as RNA editing at speciﬁc
nucleotide positions [15,16].
The data presented here concerning splice variants encoding
proteins with individual antagonizing actions and combined syner-
gistic effects on apoptosis suggest the possibility that regulation of
cell death can be partially controlled by the expression of varying
levels of MCL-1 transcripts. Future studies conﬁrming the presence
of endogenous MCL-1ES protein in cells and exploring pathophys-iological cues that regulate the particular splicing events would be
required.
Acknowledgements
This work was supported by the Basic Science Research Pro-
gram through the National Research Foundation of Korea (NRF)
funded by the Ministry of Education, Science and Technology
(2009-0066379). Additional support was provided by a grant from
the Pioneer Research Program for Converging Technology of the
Ministry of Education, Science and Technology, Republic of Korea
(M1071118001-08M1118-00110).Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2009.08.006.
References
[1] Opferman, J.T., Letai, A., Beard, C., Sorcinelli, M.D., Ong, C.C. and Korsmeyer, S.J.
(2003) Development and maintenance of B and T lymphocytes requires
antiapoptotic MCL-1. Nature 426, 671–676.
[2] Puthalakath, H. et al. (2007) ER stress triggers apoptosis by activating BH3-
only protein Bim. Cell 129, 1337–1349.
[3] Akgul, C., Moulding, D.A. and Edwards, S.W. (2004) Alternative splicing of Bcl-
2-related genes: functional consequences and potential therapeutic
applications. Cell Mol. Life Sci. 61, 2189–2199.
[4] Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P. and Craig, R.W. (1993) MCL1, a
gene expressed in programmed myeloid cell differentiation, has sequence
similarity to BCL2. Proc. Natl. Acad. Sci. USA 90, 3516–3520.
[5] Bae, J., Leo, C.P., Hsu, S.Y. and Hsueh, A.J. (2000) MCL-1S, a splicing variant of
the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic
protein possessing only the BH3 domain. J. Biol. Chem. 275, 25255–25261.
[6] Bingle, C.D., Craig, R.W., Swales, B.M., Singleton, V., Zhou, P. and Whyte, M.K.
(2000) Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene
product that promotes cell death. J. Biol. Chem. 275, 22136–22146.
[7] Soleymanlou, N. et al. (2007) Hypoxic switch in mitochondrial myeloid cell
leukemia factor-1/Mtd apoptotic rheostat contributes to human trophoblast
cell death in preeclampsia. Am. J. Pathol. 171, 496–506.
[8] Kim, J.H. et al. (2009) HIP1R interacts with a member of Bcl-2 family, BCL2L10,
and induces BAK-dependent cell death. Cell Physiol. Biochem. 23, 43–52.
[9] Arnoult, D. (2008) Apoptosis-associated mitochondrial outer membrane
permeabilization assays. Methods 44, 229–234.
[10] Cocquet, J., Chong, A., Zhang, G. and Veitia, R.A. (2006) Reverse transcriptase
template switching and false alternative transcripts. Genomics 88, 127–131.
[11] Mendelman, L.V., Petruska, J. and Goodman, M.F. (1990) Base mispair
extension kinetics. Comparison of DNA polymerase alpha and reverse
transcriptase. J. Biol. Chem. 265, 2338–2346.
[12] Huang, M.M., Arnheim, N. and Goodman, M.F. (1992) Extension of base
mispairs by Taq DNA polymerase: implications for single nucleotide
discrimination in PCR. Nucleic Acids Res. 20, 4567–4573.
[13] Chong, A., Zhang, G. and Bajic, V.B. (2004) Information for the Coordinates of
Exons (ICE): a human splice sites database. Genomics 84, 762–766.
[14] Boise, L.H. et al. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant
regulator of apoptotic cell death. Cell 74, 597–608.
[15] Bass, B.L. (2002) RNA editing by adenosine deaminases that act on RNA. Annu.
Rev. Biochem. 71, 817–846.
[16] Riedmann, E.M., Schopoff, S., Hartner, J.C. and Jantsch, M.F. (2008) Speciﬁcity
of ADAR-mediated RNA editing in newly identiﬁed targets. RNA 14, 1110–
1118.
